Cor Vasa 2011, 53(4-5):268-272 | DOI: 10.33678/cor.2011.060

Preclinical atherosclerosis as a cause of venous thromboembolism

Ondřej Auzký1,*, Libuše Pagáčová2, Jan Piťha1
1 Laboratoř pro výzkum aterosklerózy
2 Autotransfuzní jednotka, Institut klinické a experimentální medicíny, Praha, Česká republika

Despite the traditionally different perception of venous and arterial thromboses, both entities share common characteristics and risk factors. The common features and high prevalence of venous and arterial thromboses in the population raise the question of an interaction of the causes and consequences of both disorders. The thrombophilic action with a possible systemic impact of atherosclerosis has been described. Research on the impact of atherosclerosis on an increase in the risk of venous thromboembolism has brought inconclusive results so far. Published trials differed in the study design and populations. Recent results show an increased prevalence of the risk factors of atherosclerosis in patients with defined thrombophilia and venous thromboembolism, and an increased prevalence of preclinical atherosclerosis detected by ultrasound in patients with unprovoked venous thromboembolism. Current clinical practice shows that there is a need for improved stratification of the risk of venous thromboembolism and of the risk/benefit ratio of anticoagulant treatment. Ultrasound assessment of preclinical atherosclerosis and assessment of traditional risk factors of atherosclerosis may help to identify patients at increased risk of venous thromboembolism.

Keywords: Venous thromboembolism; Risk factors; Preclinical atherosclerosis; Thrombophilia

Published: April 1, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Auzký O, Pagáčová L, Piťha J. Preclinical atherosclerosis as a cause of venous thromboembolism. Cor Vasa. 2011;53(4-5):268-272. doi: 10.33678/cor.2011.060.
Download citation

References

  1. Gillum RF. Pulmonary embolism and thrombophlebitis in the United States, 1970-1985. Am Heart J 1987;114:1262-1264. Go to original source... Go to PubMed...
  2. Nordström M, Lindblad B, Bergqvist D, Kjellström T. A prospective study of the incidence of deep-vein thrombosis within a defined urban population. J Intern Med 1992;232:155-160. Go to original source... Go to PubMed...
  3. Anderson FA, Wheeler HB, Goldberg RJ, et al. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worchester DVT study. Arch Intern Med 1991;151:933-938. Go to original source...
  4. Oger E. Incidence of venous thromboembolism: a community-based study in Western France. Thromb Haemost 2000;83:657-660. Go to original source... Go to PubMed...
  5. Silverstein MD, Heit JA, Mohr DN, et al. Trends in the incidence of deep vein thrombosis and pulmonary embolism. A 25-year population-based study. Arch Intern Med 1998;158:585-593. Go to original source... Go to PubMed...
  6. Auzký O, Piťha J. Výskyt a příčiny hluboké žilní trombózy dolních končetin v neselektované populaci interních pacientů. Cor Vasa 2005;47:45-49.
  7. Mackman N. Triggers, targets, and treatments for thrombosis. Nature 2008;451:914-918. Go to original source... Go to PubMed...
  8. Holvoet P, Collen D. Thrombosis and atherosclerosis. Curr Opin Lipidol 1997;8:320-328. Go to original source... Go to PubMed...
  9. Anderson TJ. Nitric oxide, atherosclerosis and the clinical relevance of endothelial dysfunction. Heart Fail Rev 2003;8:71-86. Go to original source... Go to PubMed...
  10. Blann AD. Assessment of endothelial dysfunction: focus on atherothrombotic disease. Pathophysiol Haemost Thromb 2003;33:256-261. Go to original source... Go to PubMed...
  11. Davignon J, Ganz P. Role of endothelial dysfunction in atherosclerosis. Circulation 2004;109:III27-III32. Go to original source... Go to PubMed...
  12. Cortellaro M, Baldassarre D, Cofrancesco E, et al. Relation between hemostatic variables and increase of common carotid intima-media thickness in patients with peripheral arterial disease. Stroke 1996;27:450-454. Go to original source... Go to PubMed...
  13. Sambola A, Osende J, Hathcock J, et al. Role of risk factors in the modulation of tissue factor aktivity and blood thrombogenicity. Circulation 2003;107:973-977. Go to original source... Go to PubMed...
  14. Salomaa V, Stinson V, Kark JD, et al. Association of fibrinolytic parameters with early atherosclerosis. The ARIC Study. Atherosclerosis Risk in Communities Study. Circulation 1995;91:284-290. Go to original source... Go to PubMed...
  15. Švehla C, Ryšánek K, Koenig J, et al. Hyperkolagulace krve u arteriosklerózy. Čas Lék Čes 1965;40:1087-1092.
  16. Švehla C. Some findings on hypercoagulation mechanism in relation to atherosclerosis. Rev Czech Med 1969;15:65-78.
  17. Sobieszcyk P, Fishbein MC, Goldhaber SZ. Acute pulmonary embolism. Don't ignore the platelets. Circulation 2002;106:1748-1749. Go to original source... Go to PubMed...
  18. Migliacci R, Becattini C, Pesavento R, et al. Endothelial dysfunction in patients with spontaneous venous thromboembolism. Haematologica 2007;92:812-818. Go to original source... Go to PubMed...
  19. Jezovnik MK, Poredos P. Idiopathic venous thrombosis is related to systemic inflammatory response and to increased levels of circulating markers of endothelial dysfunction. Int Angiol 2010;29:226-231. Go to PubMed...
  20. Ageno W, Prandoni P, Romualdi E, et al. The metabolic syndrome and the risk of venous thrombosis: a case-control study. J Thromb Haemost 2006;4:1914-1918. Go to original source... Go to PubMed...
  21. Ageno W, Becattini C, Brighton T, et al. Cardiovascular risk factors and venous thromboembolism: a meta-analysis. Circulation 2008;117:93-102. Go to original source... Go to PubMed...
  22. Vaya A, Mira Y, Ferrando F, et al. Hyperlipidaemia and venous thromboembolism in patients lacking thrombophilic risk factors. Br J Haematol 2002;118:255-259. Go to original source... Go to PubMed...
  23. Lowe GD. Common risk factors for both arterial and venous thrombosis. Br J Haematol 2008;140:488-495. Go to original source... Go to PubMed...
  24. Tsai AW, Cushman M, Rosamond WD, et al. Cardiovascular risk factors and venous thromboembolism incidence: the longitudinal investigation of thromboembolism etiology. Arch Intern Med 2002;162:1182-1189. Go to original source... Go to PubMed...
  25. Rosendaal FR, Siscovick DS, Schwartz SM, et al. Factor V Leiden (resistance to activated protein C) increases the risk of myocardial infarction in young women. Blood 1997;89:2817-2821. Go to original source...
  26. Eitzman DT, Westrick RJ, Shen Y, et al. Homozygosity for factor V Leiden leads to enhanced thrombosis and atherosclerosis in mice. Circulation 2005;111:1822-1825. Go to original source... Go to PubMed...
  27. Bank I, Libourel EJ, Middeldorp S, et al. Prothrombin 20210A mutation: a mild risk factor for venous thromboembolism but not for arterial thrombotic disease and pregnancy-related complications in a family study. Arch Intern Med 2004;164:1932-1937. Go to original source... Go to PubMed...
  28. Weischer M, Juul K, Zacho J, et al. Prothrombin and risk of venous thromboembolism, ischemic heart disease and ischemic cerebrovascular disease in the general population. Atherosclerosis 2010;208:480-483. Go to original source... Go to PubMed...
  29. Mahmoodi BK, Brouwer JL, Veeger NJ, van der Meer J. Hereditary deficiency of protein C or protein S confers increased risk of arterial thromboembolic events at a young age: results from a large family cohort study. Circulation 2008;118:1659-1667. Go to original source... Go to PubMed...
  30. Folsom AR, Ohira T, Yamagishi K, Cushman M. Low protein C and incidence of ischemic stroke and coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study. J Thromb Haemost 2009;7: 1774-1778. Go to original source... Go to PubMed...
  31. Dönmez Y, Kanadasi M, Tanriverdi K, et al. Prothrombin 20210GA and factor V Leiden mutations in patients less than 55 years old with myocardial infarction. Jpn Heart J 2004;45:505-512. Go to original source... Go to PubMed...
  32. Baccarelli A, Martinelli I, Zanobetti A, et al. Exposure to particulate air pollution and risk of deep vein thrombosis. Arch Intern Med 2008;168:920-927. Go to original source... Go to PubMed...
  33. Brook RD. Air pollution: what is bad for the arteries might be bad for the veins. Arch Intern Med 2008;168:909-911. Go to original source... Go to PubMed...
  34. Glynn RJ, Danielson E, Fonseca FA, et al. A randomized trial of rosuvastatin in the prevention of venous thromboembolism. N Engl J Med 2009;360:1851-1861. Go to original source... Go to PubMed...
  35. Steffen LM, Folsom AR, Cushman M, et al. Greater fish, fruit, and vegetable intakes are related to lower incidence of venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology. Circulation 2007;115:188-195. Go to original source... Go to PubMed...
  36. Prandoni P. Links between arterial and venous disease. J Intern Med 2007;262:341-350. Go to original source... Go to PubMed...
  37. Piťha J. Detekce preklinické aterosklerózy. Intern Med 2007;4:175-177.
  38. Holaj R, Spáčil J, Petrášek J, et al. Vztah tloušťky intimy a medie společné karotidy, aterosklerotických plátů na karotidách a manifestní aterosklerózy tepen dolních končetin ke koronární ateroskleróze. Čas Lék Čes 1998; 137:716-720.
  39. Cífková R, Býma S, Češka R, et al. Prevence kardiovaskulárních onemocnění v dospělém věku - společné doporučení českých odborných společností. Vnitř Lék 2005;51:1021-1036.
  40. Belcaro G, Barsotti A, Nicolaides AN. Ultrasonic biopsy: a non-invasive screening technique to evaluate the cardiovascular risk and to follow up the progression and the regression of arteriosclerosis. Vasa 1991;20:40-50.
  41. Belcaro G, Nicolaides AN, Laurora G, et al. Ultrasound morphology classification of the arterial wall and cardiovascular events in a 6-year follow-up study. Arterioscler Thromb Vasc Biol 1996;16:851-856. Go to original source... Go to PubMed...
  42. Veller MG, Fisher CM, Nicolaides AN, et al. Measurement of the ultrasonic intima-media complex thickness in normal subjects. J Vasc Surg 1993;17:719-725 Go to original source...
  43. Schmidt C, Fagerberg B, Hulthe J. Non-stenotic echolucent ultrasound-assessed femoral artery plaques are predictive for future cardiovascular events in middle-aged men. Atherosclerosis 2005;181:125-130. Go to original source... Go to PubMed...
  44. Prandoni P, Bilora F, Marchiori A, et al. An association between atherosclerosis and venous thrombosis. N Engl J Med 2003;348:1435-1441. Go to original source... Go to PubMed...
  45. Hong C, Zhu F, Du D, et al. Coronary artery calcification and risk factors for atherosclerosis in patients with venous thromboembolism. Atherosclerosis 2005;183:169-174. Go to original source... Go to PubMed...
  46. Becattini C, Agnelli G, Prandoni P, et al. A prospective study on cardiovascular events after acute pulmonary embolism. Eur Heart J 2005;26:77-83. Go to original source... Go to PubMed...
  47. Bova C, Marchiori A, Noto A, et al. Incidence of arterial cardiovascular events in patients with idiopathic venous thromboembolism. A retrospective cohort study. Thromb Haemost 2006;96:132-136. Go to original source... Go to PubMed...
  48. Sørensen HT, Horvath-Puho E, Pedersen L, et al. Venous thromboembolism and subsequent hospitalisation due to acute arterial cardiovascular events: a 20-year cohort study. Lancet 2007;370:1773-1779. Go to original source... Go to PubMed...
  49. van der Hagen PB, Folsom AR, Jenny NS, et al. Subclinical atherosclerosis and the risk of future venous thrombosis in the Cardiovascular Health Study. J Thromb Haemost 2006:1903-1908. Go to original source... Go to PubMed...
  50. Reich LM, Folsom AR, Key NS, et al. Prospective study of subclinical atherosclerosis as a risk factor for venous thromboembolism. J Thromb Haemost 2006;4:1909-1913. Go to original source... Go to PubMed...
  51. Grant PJ. Is hypercoagulability an issue in arterial thrombosis? Yes. J Thromb Haemost 2004;2:690-691. Go to original source... Go to PubMed...
  52. Reitsma PH. Is hypercoagulability an issue in arterial thrombosis? No. J Thromb Haemost 2004;2:692-694. Go to original source... Go to PubMed...
  53. Jezovnik MK, Poredos P, Lusa L. Idiopathic venous thrombosis is associated with preclinical atherosclerosis. J Atheroscler Thromb 2010;17:304-311. Go to original source... Go to PubMed...
  54. Auzký O, Pagáčová L, Šejda T, Piťha J. Preclinical atherosclerosis and other determinants of venous thromboembolism in patients with thrombophilias. Physiol Res 2010;59:721-728. Go to original source...
  55. Remkova A, Remko M. The role of renin-angiotensin system in prothrombotic state in essential hypertension. Physiol Res 2010;59:13-23. Go to original source...
  56. Glynn RJ, Rosner B. Comparison of risk factors for the competing risks of coronary heart disease, stroke, and venous thromboembolism. Am J Epidemiol 2005;162:975-982. Go to original source... Go to PubMed...
  57. Quist-Paulsen P, Naess IA, Cannegieter SC, et al. Arterial cardiovascular risk factors and venous thrombosis: results from a population-based, prospective study (the HUNT 2). Haematologica 2010;95:119-125. Go to original source... Go to PubMed...
  58. Eichinger S, Weltermann A, Mannhalter C, et al. The risk of recurrent venous thromboembolism in heterozygous carriers of factor V Leiden and a first spontaneous venous thromboembolism. Arch Intern Med 2002; 162:2357-2360. Go to original source... Go to PubMed...




Cor et Vasa

You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.